Lumosa Therapeutics Co., Ltd. (TPEX: 6535)

Lumosa Therapeutics Revenue

Lumosa Therapeutics had revenue of 6.37M TWD in the quarter ending September 30, 2024, a decrease of -60.85%. This brings the company's revenue in the last twelve months to 37.82M, down -28.38% year-over-year. In the year 2023, Lumosa Therapeutics had annual revenue of 56.92M with 113.63% growth.

• Revenue (ttm): 37.82M
• Revenue Growth: -28.38%
• P/S Ratio: n/a
• Revenue / Employee: 804.57K
• Employees: 47
• Market Cap: 32.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	56.92M	30.27M	113.63%
Dec 31, 2022	26.64M	9.28M	53.45%
Dec 31, 2021	17.36M	-4.29M	-19.81%
Dec 31, 2020	21.65M	-150.39M	-87.42%
Dec 31, 2019	172.04M	111.43M	183.83%